Generation of three CRISPR/Cas9 edited human induced pluripotent stem cell lines (DHMi005-A-5, DHMi005-A-6 and DHMi005-A-7) carrying a Holt-Oram Syndrome patient-specific TBX5 mutation with known cardiac phenotype and a FLAG-tag after exon 9 of the TBX5 gene

Stem Cell Res. 2023 Jun:69:103123. doi: 10.1016/j.scr.2023.103123. Epub 2023 May 16.

Abstract

TBX5 is a transcription factor (TF) playing essential role during cardiogenesis. It is well known that TF mutations possibly result in non- or additional binding of the DNA due to conformational changes of the protein. We introduced a Holt-Oram Syndrome (HOS) patient-specific TBX5 mutation c.920_C > A heterozygously in a healthy induced pluripotent stell cell (iPSC) line. This TBX5 mutation results in conformational changes of the protein and displayed ventricular septal defects in the patient itself. Additionally we introduced a FLAG-tag on the TBX5 mutation-carrying allele. The resulting heterozygous TBX5-FLAG iPSC lines are a powerful tool to investigate altered TF activity bonding.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abnormalities, Multiple
  • CRISPR-Cas Systems
  • Exons / genetics
  • Heart Defects, Congenital
  • Heart Septal Defects, Atrial
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Lower Extremity Deformities, Congenital
  • Mutation / genetics
  • Phenotype
  • T-Box Domain Proteins / genetics
  • T-Box Domain Proteins / metabolism
  • Transcription Factors / genetics
  • Transcription Factors / metabolism
  • Upper Extremity Deformities, Congenital

Substances

  • A 7
  • T-Box Domain Proteins
  • Transcription Factors

Supplementary concepts

  • Holt-Oram syndrome